Dozee Raises $8.3M to Boost Global Expansion and R&D Capabilities

Bengaluru-based healthtech startup Dozee has secured ₹71.5 crore (~$8.3 million) in a mix of equity and debt funding to accelerate its global expansion and strengthen its research and development (R&D) initiatives. The latest funding round saw participation from Temasek Trust’s impact-first investment arm C3H, Stockhausen International Pte, and a group of undisclosed strategic investors. According to filings with the Ministry of Corporate Affairs (MCA), C3H invested ₹6.3 crore as equity, while Stockhausen International contributed ₹58.5 crore in the form of debt. The remaining amount came from other strategic backers.

Admin Mar 28, 2025 13 0

Bengaluru-based healthtech startup Dozee has secured ₹71.5 crore (~$8.3 million) in a mix of equity and debt funding to accelerate its global expansion and strengthen its research and development (R&D) initiatives.

The latest funding round saw participation from Temasek Trust’s impact-first investment arm C3H, Stockhausen International Pte, and a group of undisclosed strategic investors. According to filings with the Ministry of Corporate Affairs (MCA), C3H invested ₹6.3 crore as equity, while Stockhausen International contributed ₹58.5 crore in the form of debt. The remaining amount came from other strategic backers.

Founded in 2015 by Mudit Dandwate and Gaurav Parchani, Dozee specializes in AI-powered, contactless remote patient monitoring systems that track vital health parameters such as heart rate, respiration rate, blood pressure, and body temperature. The company’s Early Warning System proactively alerts healthcare professionals of potential health deteriorations, enabling timely interventions.

Dozee intends to deploy the newly raised capital to scale its presence to over 2,000 hospitals across 100 districts in India, while also expanding internationally, targeting key markets like the US and UAE. The company also plans to enhance its product portfolio and deepen its R&D capabilities.

In FY24, Dozee reported a 148% growth in revenue from operations, reaching ₹5.2 crore compared to ₹2.1 crore in FY23. Including other income, total revenue stood at ₹6.5 crore. The company successfully reduced its net loss by 19% to ₹68 crore, down from ₹84.4 crore in the previous fiscal year. Operating expenses also fell by 15% to ₹74.5 crore, with employee costs—its largest expense—dropping by 12% to ₹47 crore.

Despite having to lay off approximately 40 employees in 2023 to reduce losses, the company remains optimistic about achieving profitability in India. It is currently hiring talent across departments such as data science, product development, and marketing.

This funding comes on the heels of Dozee’s ₹51.8 crore ($6 million) Series A2 round in April 2023, backed by Prime Venture Partners, YourNest VC, State Bank of India, and others. With the latest round, Dozee’s total capital raised now approaches $20 million.

Dozee competes with other Indian healthtech startups including Zyla Health, Fix Health, Zivov, and Cardiac Design Labs as it continues its mission to revolutionize critical care infrastructure globally.